Valley Brook Capital Group Inc. Purchases Shares of 480 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Valley Brook Capital Group Inc. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 480 shares of the medical equipment provider’s stock, valued at approximately $236,000.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after acquiring an additional 493,126 shares during the last quarter. Capital World Investors boosted its position in Intuitive Surgical by 1.0% during the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after purchasing an additional 73,634 shares during the period. American Century Companies Inc. increased its holdings in shares of Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after purchasing an additional 70,556 shares during the last quarter. Clearbridge Investments LLC raised its position in shares of Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after purchasing an additional 30,449 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Intuitive Surgical by 15.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock worth $659,893,000 after buying an additional 197,841 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have weighed in on ISRG. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company increased their target price on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Insider Activity

In related news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the company’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now owns 821 shares of the company’s stock, valued at $402,519.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 68,246 shares of company stock worth $33,839,308. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG traded up $1.10 during trading on Thursday, hitting $516.65. 142,563 shares of the stock traded hands, compared to its average volume of 1,451,602. The business has a 50 day moving average price of $492.30 and a 200 day moving average price of $450.05. Intuitive Surgical, Inc. has a twelve month low of $269.49 and a twelve month high of $525.00. The company has a market cap of $184.02 billion, a price-to-earnings ratio of 82.89, a PEG ratio of 4.99 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.